An integrative approach to identify YB-1-interacting proteins required for cisplatin resistance in MCF7 and MDA-MB-231 breast cancer cells
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-07-10
著者
-
Langlois Mathieu
Department Of Molecular Biology Medical Biochemistry And Pathology Laval University Quebec City
-
Chow Donald
Clinical Translational Research Division Translational Genomics Research Institute
-
GARAND Chantal
Department of Molecular Biology, Medical Biochemistry, and Pathology, Laval University Quebec City
-
GUAY David
Feldan Bio Inc.
-
SEREDUK Chris
Clinical Translational Research Division, Translational Genomics Research Institute
-
TSOFACK Serges
Department of Molecular Biology, Medical Biochemistry, and Pathology, Laval University Quebec City
-
PERREAULT Eve
Department of Molecular Biology, Medical Biochemistry, and Pathology, Laval University Quebec City
-
YIN Hongwei
Clinical Translational Research Division, Translational Genomics Research Institute
-
LEBEL Michel
Department of Molecular Biology, Medical Biochemistry, and Pathology, Laval University Quebec City
-
Lebel Michel
Department Of Molecular Biology Medical Biochemistry And Pathology Laval University Quebec City
-
Sereduk Chris
Clinical Translational Research Division Translational Genomics Research Institute
-
Perreault Eve
Department Of Molecular Biology Medical Biochemistry And Pathology Laval University Quebec City
-
Garand Chantal
Department Of Molecular Biology Medical Biochemistry And Pathology Laval University Quebec City
-
Yin Hongwei
Clinical Translational Research Division Translational Genomics Research Institute
-
Tsofack Serges
Department Of Molecular Biology Medical Biochemistry And Pathology Laval University Quebec City
関連論文
- An integrative approach to identify YB-1-interacting proteins required for cisplatin resistance in MCF7 and MDA-MB-231 breast cancer cells
- The human endonuclease III enzyme is a relevant target to potentiate cisplatin cytotoxicity in Y-box-binding protein-1 overexpressing tumor cells